Related Experiment Videos
Photocoagulation treatment for clinically significant radiation macular oedema
J L Kinyoun1, R W Zamber, B S Lawrence
1Department of Ophthalmology, University of Washington, Seattle 98195-0001, USA.
The British Journal of Ophthalmology
|February 1, 1995
Summary
Macular photocoagulation effectively treats radiation-induced macular edema, improving vision in most patients. This treatment offers a promising solution for vision loss caused by radiation retinopathy.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Treatments
Background:
- Macular edema is a primary cause of vision loss in radiation retinopathy.
- Effective treatments for this vision-threatening complication are needed.
Purpose of the Study:
- To evaluate the efficacy of macular photocoagulation for clinically significant radiation macular edema (CSRMO).
Main Methods:
- 12 eyes (8 patients) with CSRMO underwent photocoagulation.
- CSRMO was defined by central macular thickening, exudates, or macular thickening.
Main Results:
- Median visual acuity improved from 20/100 preoperatively to 20/75 at final follow-up (mean 39 months).
- Visual acuity improved in 67% of eyes; 50% achieved complete CSRMO resolution.
- 17% of eyes showed anatomical improvement with reduced CSRMO criteria.
Conclusions:
- Macular photocoagulation is effective in reducing macular edema.
- The treatment improves vision in eyes affected by CSRMO.